Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-Center, Open-Labelled, Pralatrexate Study in Asian Patients With Peripheral T-cell Lymphoma After Prior Therapy

NCT03150602 is registered in ClinicalTrials.gov with Taiwan Mundipharma Pharmaceuticals Ltd. as lead sponsor.

NCT NCT03150602
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03150602 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-Center, Open-Labelled, Pralatrexate Study in Asian Patients With Peripheral T-cell Lymphoma After Prior Therapy
Lead sponsor
Taiwan Mundipharma Pharmaceuticals Ltd.
Phase
Phase 4
Overall status
Unknown status
Start date
August 30, 2016
Completion date
December 31, 2020
Enrollment
22 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

peripheral t cell lymphoma, progression, disease